eCM 2018
DOI: 10.22203/ecm.v035a22
|View full text |Cite
|
Sign up to set email alerts
|

Improved tendon healing using bFGF, BMP-12 and TGFβ1 in a rat model

Abstract: Several growth factors (GFs) are expressed as tendons heal, but it remains unknown whether their combined application enhances the healing process. This matter was addressed by applying a combination of basic fibroblast growth factor (bFGF), bone morphogenetic protein 12 (BMP-12) and transforming growth factor beta 1 (TGFβ1) in a rat Achilles tendon transection model. GFs were applied in one of the three following ways: i) direct application of all three factors at the time of surgery; ii) sequential, tiered p… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

0
35
0
1

Year Published

2018
2018
2024
2024

Publication Types

Select...
6
2

Relationship

0
8

Authors

Journals

citations
Cited by 29 publications
(36 citation statements)
references
References 46 publications
0
35
0
1
Order By: Relevance
“…There are several limitations in our study. Tgf- β 1 was often combined with other inducers for tendon differentiation [ 14 , 43 ], although its use alone had definite capability to induce tenogenic differentiation which was used to compare with the inductivity of hypoxia in this study. In addition, we did not seed fluorescent-labeled MSCs in the wound gap to investigate the role of hypoxia-induced MSCs in tenogenesis in vivo.…”
Section: Discussionmentioning
confidence: 99%
“…There are several limitations in our study. Tgf- β 1 was often combined with other inducers for tendon differentiation [ 14 , 43 ], although its use alone had definite capability to induce tenogenic differentiation which was used to compare with the inductivity of hypoxia in this study. In addition, we did not seed fluorescent-labeled MSCs in the wound gap to investigate the role of hypoxia-induced MSCs in tenogenesis in vivo.…”
Section: Discussionmentioning
confidence: 99%
“…Certain growth factors could act directly on target cells present in the injured site to facilitate the healing process. These include insulin-like growth factor-1 (IGF-1), basic fibroblast growth factor (bFGF), platelet-derived growth factor (PDGF), and transforming growth factor-β (TGF-β) [2][3][4][5][6][7][8]. However, their clinical use is still limited because of their high costs, short preservation period, and limited clinical availability.…”
Section: Introductionmentioning
confidence: 99%
“…The ability of this technology to accelerate healing of the transected rat Achilles tendon has been previously confirmed. 15 In the IP group, the longitudinally opened paratenon was preserved and closed together with the skin using single stitches. In the RP group, the paratenon was resected completely, 20 the GF-loaded sponge placed into the tendon defect, and the skin thoroughly closed with single stitches, while the collagen sponge was secured with the skin sutures in place.…”
Section: Methodsmentioning
confidence: 99%
“…16 Tendons were tested with a constant displacement rate of 1000 mm/min, which corresponds to dynamic loading of the Achilles tendon in vivo. 15 Force and elongation were continuously recorded, and the maximal load to failure (N) was assessed from the corresponding load-elongation graph. Tendon stiffness (N/mm) was calculated from the linear part of the force-elongation curve and correlated to the cross-sectional area and strain to determine the elastic modulus (MPa).…”
Section: Methodsmentioning
confidence: 99%
See 1 more Smart Citation